Coronary flow reserve assessment by Doppler echocardiography in children with and without congenital heart defect: comparison with invasive technique.
To evaluate whether transthoracic Doppler echocardiography can reliably measure coronary flow velocity (CFV) and CFV reserve (CFVR) in the left anterior descending coronary artery (LAD) in children, we examined 12 patients who had a history of Kawasaki disease without stenosis or aneurysm formation of coronary artery and 9 patients who had congenital heart disease (ventricular septal defect in 6, patent ductus arteriosus in 2, tricuspid atresia in 1). The pulmonary-to-systemic flow ratio ranged from 1.7 to 2.8. CFV in the proximal LAD was measured by transthoracic Doppler echocardiography at the time of Doppler guidewire examination. CFV in the proximal LAD was measured at baseline and hyperemic conditions by both transthoracic Doppler echocardiography and Doppler guidewire techniques. CFVR was defined as "the ratio of peak hyperemic to basal CFV in the proximal LAD." Clear envelopes of basal and hyperemic CFV in the proximal LAD were obtained in 19 of 21 patients by transthoracic Doppler echocardiography. There was a significant correlation between transthoracic Doppler echocardiography and Doppler guidewire methods for the measurements of CFV (r = 0.84, P <.0001). The mean difference between the 2 methods was -0.5 +/- 5.9 cm/s. CFVR from transthoracic Doppler echocardiography correlated well with that from Doppler guidewire examinations (r = 0.83, P <.0001). The mean difference between the 2 methods was 0.06 +/- 0.24. Noninvasive measurement of CFV and CFVR in the proximal LAD using transthoracic Doppler echocardiography accurately reflects invasive measurement of CFV and CFVR by Doppler guidewire method in pediatric patients with various heart diseases.
Harada
Kenji
K
Department of Pediatrics, Akita University School of Medicine, Japan. kharada@doc.med.akita-u-ac.jp
Yasuoka
Kenji
K
Tamura
Masamichi
M
Toyono
Manatomo
M
D000251:Adenosine Triphosphatases / Q000008:administration & dosage; D000328:Adult; D001158:Arteries / Q000503:physiopathology; D001783:Blood Flow Velocity / Q000187:drug effects / Q000502:physiology*; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D002648:Child; D002669:Child Welfare; D002675:Child, Preschool; D003326:Coronary Circulation / Q000187:drug effects / Q000502:physiology*; D003331:Coronary Vessels / Q000503:physiopathology; D015150:Echocardiography, Doppler; D006330:Heart Defects, Congenital / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000503:physiopathology*; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007223:Infant; D007229:Infant Welfare; D007262:Infusions, Intravenous; D015588:Observer Variation; D013223:Statistics as Topic
D000251:Adenosine Triphosphatases